Insights
Key Steps to Strengthen FDA Inspection Readiness
For pharmaceutical and biopharma companies, FDA inspections are critical checkpoints in the journey toward regulatory approval. New Drug Applications (NDAs) require meticulous preparation to ensure
Top Reasons FDA IDE Submissions Are Deficient and How to Fix Them
For medical device companies seeking to conduct clinical trials in the United States, an Investigational Device Exemption (IDE) application is essential. A well-prepared IDE submission
FDA Investigational Device Exemption (IDE) Review Timeline Explained
How Long Does FDA IDE Review Take? Key Milestones Explained For medical device innovators and biotechnology companies developing diagnostic or therapeutic devices, obtaining approval to
Building Strong Data Integrity Systems for FDA Regulatory Inspections
Strengthening Data Integrity Controls Before an FDA Inspection In recent years, data integrity has become one of the most closely scrutinized areas during regulatory inspections.
Best Practices for Developing an FDA-Inspection-Ready QMS
How to Develop an FDA-Inspection-Ready Quality Management System For biotech and pharmaceutical companies, regulatory inspections are not simply compliance events. They are a comprehensive evaluation
Risk-Based Approach to Technical Transfer in the Pharmaceutical Industry
Risk-Based Technology Transfer in Pharma Technology transfer in pharmaceutical manufacturing is rarely a simple handoff between development and production teams. It involves transferring complex knowledge